GlassScriptPhysician profile
Tad Manalo
NPI 1023521036
$2,698.26
in general payments reported to CMS, 2019-2025
8 companies · $2,091 in 2025
The $2,091 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $134 · 2024: $473 · 2025: $2,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,217 · Food and Beverage: $1,026 · Education: $305 · Entertainment: $16.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,216.52 |
| Food and Beverage | $1,026.23 |
| Education | $305.00 |
| Entertainment | $16.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,770.87 | 2022-2025 | Ams 700, Advance Xp, Rezum Generator |
| Medical Device Business Services, INC. | $305.00 | 2024 | |
| Koelis INC. | $189.37 | 2025 | |
| Innovation Technologies INC | $170.41 | 2024-2025 | Irrisept |
| Olympus America INC. | $134.65 | 2024 | Itind System |
| Coloplast Corp | $70.30 | 2025 | |
| Teleflex LLC | $34.89 | 2025 | Barrigel |
| Janssen Biotech, INC. | $22.77 | 2025 | Rybrevant, Carvykti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tad Manalo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.